Mosaic Immunoengineering Stock Price, News & Analysis
Company Description
Mosaic Immunoengineering (OTC Link: CPMV) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.4M.
CPMV stock has declined 8.1% over the past year. Shares last traded at $0.6949.
On a trailing twelve-month basis, Mosaic Immunoengineering and diluted earnings per share of $-0.10.
This page provides a comprehensive overview of CPMV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mosaic Immunoengineering (CPMV) stock last traded at $0.6949. Over the past 12 months, the stock has lost 8.1%. At a market capitalization of $2.4M, CPMV is classified as a micro-cap stock with approximately 7.2M shares outstanding.
Latest News
Mosaic Immunoengineering has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include acquisition, conferences. View all CPMV news →
SEC Filings
Mosaic Immunoengineering has filed 4 recent SEC filings, including 1 Form 10-K, 1 Form NT 10-K, 1 Form 10-Q, 1 Form NT 10-Q. The most recent filing was submitted on April 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CPMV SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.10. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Mosaic Immunoengineering (CPMV) currently stands at 132 shares, down 27.1% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 1366.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Mosaic Immunoengineering (CPMV) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.7 days.
CPMV Company Profile & Sector Positioning
Mosaic Immunoengineering (CPMV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CPMV often look at related companies in the same sector, including Restart Life (NMLSF), Avenue Therapeutics Inc (ATXI), Nascent Biotech (NBIO), Mynd Life Scienc (MYNDF), and Algernon Health (AGNPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CPMV's relative position within its industry.